A biochemist's surprising discovery about a coenzyme found in every cell of the human body is quietly reshaping how longevity researchers think about energy, aging, and the decade between 40 and 50.
NAD+ · Nicotinamide Adenine Dinucleotide
The coenzyme present in every living cell — and declining in yours right now.
Illustration: The NAD+ molecule — a coenzyme critical to over 500 enzymatic reactions in the human body. Levels drop by up to 65% between ages 30 and 70.
Richard Clarke was 47 when he noticed something he couldn't explain. A former competitive cyclist who had maintained the same training schedule for over a decade, he started waking up exhausted. Not the pleasant tiredness of hard effort — something deeper. His afternoon sharpness was gone. His recovery between sessions stretched from one day to three. His doctor ran every standard panel. Everything came back "normal."
It wasn't until Clarke stumbled across a 2023 paper in Nature Aging — the kind of research that rarely makes headlines but travels fast through longevity circles — that he found a framework that finally made sense of what he was experiencing.
The paper's conclusion was stark: by the time most people reach their mid-40s, their cells are operating with roughly half the fuel capacity they had at 20. Not because of lifestyle choices. Not because of poor diet or lack of sleep. But because of a coenzyme called NAD+ — and a biological process that no one had adequately warned them about.
"We used to think cellular decline was an inevitable consequence of aging. Now we understand it's partly a consequence of a specific, measurable deficit — one that may be addressable."
— Dr. David Sinclair, Professor of Genetics, Harvard Medical SchoolNAD+ (nicotinamide adenine dinucleotide) isn't a trendy supplement ingredient. It's a coenzyme that has existed in living organisms for billions of years. Your cells cannot produce energy without it. They cannot repair DNA without it. They cannot regulate the proteins responsible for longevity — called sirtuins — without it.
Think of it as the electrical current that powers every major system in your body simultaneously. When the current is strong, everything runs efficiently. When it weakens — which is precisely what happens with age — multiple systems begin to underperform at the same time. That's why the symptoms of NAD+ decline are so diffuse, and so easy to misattribute to "just getting older."
The research is unusually consistent for a field still considered emerging. Studies from the University of Washington, MIT, and Harvard's Sinclair Lab have all pointed to the same conclusion: restoring NAD+ levels in aging cells produces measurable improvements in energy metabolism, DNA repair capacity, and metabolic function.
A 2022 study published in Cell Metabolism examined the effect of NAD+ precursor supplementation in adults aged 45–65. Participants showed significant improvements in mitochondrial function markers and reported reductions in fatigue scores after 8 weeks of consistent use. The researchers noted that the response was strongest in participants whose baseline NAD+ levels were most depleted — consistent with the pattern seen in most adults over 40.
Once the longevity community understood what NAD+ was, the market responded quickly — and, predictably, imperfectly. The first wave of NAD+ supplements focused on two precursors: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). Both can raise NAD+ levels. Both also come with significant limitations.
NMN is expensive. A quality NMN supplement costs $60–$120 per month at effective doses. Its stability as an oral supplement has been questioned in peer-reviewed literature, with some researchers suggesting much of it degrades before reaching target tissues. NR is better absorbed but still relies on a single-pathway approach to a multi-pathway problem.
What the most recent research suggests — and what Clarke eventually discovered — is that the most effective approach to NAD+ support isn't a single powerful precursor. It's a multi-pathway strategy that simultaneously feeds the production pathways, protects against enzymatic breakdown, and activates the cellular machinery that actually uses NAD+ effectively.
Key Insight: NAD+ levels are determined not just by how much you produce, but by how much is being consumed and broken down. A supplement that only addresses production — without addressing breakdown — is solving half the equation.
In 2023, researchers published a landmark paper identifying trigonelline as a novel NAD+ precursor with a distinct mechanism from NMN or NR. Trigonelline — a compound found naturally in fenugreek seeds and coffee — activates a different biosynthesis pathway, meaning it complements rather than duplicates what other precursors do.
The finding was significant enough to generate immediate interest from supplement formulators working in the longevity space. For the first time, it was possible to design a multi-pathway NAD+ formula — one that didn't rely on a single expensive ingredient but combined several mechanisms working in parallel.
Clarke, who had by this point become something of an obsessive on the subject, began researching which products had incorporated this finding into their formulations. Most hadn't. The research was too new, the ingredient too recent. But one formulation caught his attention — and it came from an unlikely direction: a European supplement company that had been quietly building NAD+ support products for several years.
Clarke's investigation led him to examine the formulation of EnduNAD+, a supplement developed by NuviaLab in Europe. What distinguished it, in his assessment, was the approach: rather than betting everything on a single precursor at a high dose, it stacked nine synergistic compounds targeting NAD+ production, protection, and utilization simultaneously.
Delivers trigonelline — the novel NAD+ precursor identified in 2023 research. Activates a biosynthesis pathway distinct from NMN or NR, providing additive NAD+ production support.
The original NAD+ precursor. Niacin feeds the Preiss-Handler pathway directly. Combined with trigonelline, it creates a dual-pathway production approach that significantly outperforms either alone.
Apigenins inhibit CD38 — an enzyme that consumes NAD+ at an accelerating rate with age. Blocking CD38 is as important as producing NAD+, and this is the mechanism most formulas ignore entirely.
Activates sirtuin proteins (SIRT1, SIRT3) which are NAD+-dependent longevity regulators. Resveratrol essentially makes the NAD+ you produce work more effectively at the cellular level.
A powerful mitochondrial support compound. Improves mitochondrial efficiency and reduces oxidative stress — protecting the cellular machinery that uses NAD+ to produce energy.
Feeds NAD+ production via the kynurenine pathway — a third distinct biosynthesis route. Also supports serotonin and melatonin production, with positive downstream effects on sleep quality and recovery.
A universal antioxidant operating in both water-soluble and fat-soluble cellular environments. Supports mitochondrial function and glucose metabolism — reducing the metabolic load that depletes NAD+.
Increases the bioavailability of resveratrol and EGCG by up to 2,000%. Without piperine, a significant portion of these compounds pass through without being absorbed — this is the ingredient that makes the rest work.
Supports amino acid metabolism and enhances the effectiveness of niacin on NAD+ production. Also supports neurotransmitter synthesis, with cognitive and mood-related benefits.
What Clarke noted — and what sets this formulation apart from most on the market — is the inclusion of chamomile apigenins specifically for CD38 inhibition. Most NAD+ supplements only address production. This one also addresses breakdown. That's a meaningful distinction from a biochemical standpoint.
CD38 is an enzyme that dramatically increases in activity with age — and it consumes NAD+ at an extraordinary rate. Research suggests that rising CD38 activity may be a primary driver of age-related NAD+ decline, not just reduced production. A study in Cell Metabolism found that CD38-knockout mice maintained significantly higher NAD+ levels into old age compared to controls. Apigenin has been identified as one of the most effective natural CD38 inhibitors available.
9 synergistic compounds targeting NAD+ production, protection, and utilization. Formulated in Europe. Suitable for vegans. Backed by a satisfaction guarantee.
View Current Pricing →Free shipping available · Up to 20% off multi-month supply
Clarke is careful about the language he uses. He's not the type to describe anything as miraculous, and he's appropriately skeptical of testimonials in the supplement space. But eight weeks after beginning a consistent protocol, he documented changes he considered worth noting.
His morning energy — the baseline waking state that had been dragging for two years — had improved noticeably. Not dramatically, not overnight, but consistently. His recovery between training sessions returned to something closer to his experience at 40. His afternoon mental sharpness, which he'd quietly accepted as "just how it is now," returned with enough regularity that he started scheduling his most cognitively demanding work for those hours again.
He's clear that he can't attribute these changes definitively to any single cause. He acknowledges the possibility of confounding factors. But he's also been tracking his health data long enough to recognize when a variable changes.
I went in skeptical. I've taken plenty of supplements that promised cellular-level effects and delivered nothing measurable. What I can say is that my energy baseline shifted, my recovery improved, and my mental clarity in the afternoons came back in a way I hadn't experienced in a couple of years. I'll be continuing.
The research on NAD+ support is compelling, but it's worth being direct about what the evidence actually supports — and what it doesn't.
The evidence is strongest for: adults over 35–40 experiencing age-related energy decline, individuals with physically or cognitively demanding lifestyles who notice longer recovery times, and people specifically interested in supporting metabolic health and cellular longevity as a long-term strategy.
It's not a fast-acting stimulant. NAD+ support operates at a cellular level — the effects are cumulative and typically become noticeable after 4–8 weeks of consistent use. If you're looking for a pre-workout energy spike, this isn't that product.
It's not a replacement for sleep, nutrition, or exercise. The research consistently shows that NAD+ support works best as part of a lifestyle that already includes the basics. It amplifies what's already there — it doesn't substitute for it.
EnduNAD+ is manufactured in Europe, uses natural ingredients, is suitable for vegans, and is formulated specifically for adults who want to support their cellular health over the long term. It carries a satisfaction guarantee — which is the appropriate position for any supplement making claims at the cellular level.
European supplement regulation has historically been stricter than its US counterpart — which, counterintuitively, often results in more carefully formulated products. NuviaLab, the manufacturer behind EnduNAD+, operates under EU food supplement standards, which require more rigorous ingredient sourcing and quality controls than FDA DSHEA requirements.
The product ships to the United States, United Kingdom, Australia, and Canada, among other markets. But because it's not manufactured domestically and doesn't carry the marketing budgets of US supplement giants, it remains largely unknown outside the longevity research community — which is where Clarke encountered it, and where most people reading this publication will encounter it first.
That obscurity may not last. The NAD+ market is growing at a rate of over 20% annually, and formulations that combine multiple mechanisms — rather than betting everything on NMN or NR — are beginning to attract more attention from researchers and serious practitioners. When the mainstream catches up, the window of early adoption closes.
9-ingredient multi-pathway NAD+ formula. Natural ingredients, vegan-friendly, manufactured in Europe to EU standards. The 6-month supply offers the best per-day value and the longest window to experience cumulative effects.
Editorial Disclosure: This article contains affiliate links. If you purchase through these links, The NAD+ Brief may receive a commission at no additional cost to you. This does not influence our editorial coverage.
Health Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information in this article is intended for educational purposes and does not constitute medical advice. Consult a qualified healthcare professional before beginning any supplementation protocol.
References available on request. Research citations drawn from peer-reviewed publications in Nature Aging, Cell Metabolism, and related journals. Individual results vary.
EnduNAD+
Multi-pathway NAD+ support · Up to 20% off